Clinical Trial Update: Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating pegcetacoplan in combination with modified FOLFIRINOX for metastatic pancreatic ductal adenocarcinoma is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• FOLFIRINOX (modified) (modified FOLFIRINOX regimen)
• Pegcetacoplan (Pegcetacoplan)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING